An official website of the United States government

Here's how you know

U.S. Department of Health and Human Services National Institutes of Health

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH has no active Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Notices of Funding Opportunity (NOFOs); therefore, there is no April 5, 2026 receipt date (see NOT-OD-26-006). Any future NOFOs will be forecasted at Grants.gov prior to opening for applications.

Estrigenix

Estrigenix Therapeutics is a preclinical pharmaceutical development company pioneering therapies to improve women’s health, with an initial focus to drastically reduce the mental and physical effects of menopause. The first-in-class drug, EGX358, was discovered by researchers at Marquette University, Concordia University-Wisconsin, and the University of Wisconsin-Milwaukee. EGX358 will be developed further by Estrigenix to validate pharmacodynamics and safety, a key step before advancing to human clinical testing.

Contact Name:

William Donaldson

Contact Email:

[email protected]

Website: https://www.estrigenix.com/

City, State – Congressional District: Wauwatosa,

–

Technology: Drug

Funding: Aging (NIA)

NIH Projects: NIH RePorter for Estrigenix

Sponsored Event(s): MedCity INVEST | 2024